Supports projects up to 18 months focused on translational drug development to accelerate novel treatments for Parkinson's disease. Funding up to £150,000 or £200,000 for in vivo work helps generate data to prepare compounds for full-scale drug discovery with industry partners or Parkinson's Research Ventures.
Applicants must be based at a UK university, NHS Trust, or small start-up biotech company. Collaborators may be outside the UK or at biotech companies.
